Hypertensive disease
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
2322
|
1085
|
0.700 |
None |
0.964 |
56 |
2
|
1995 |
2019 |
Essential Hypertension
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
445
|
293
|
0.100 |
None |
0.778 |
18 |
3
|
1996 |
2017 |
Trichohepatoenteric Syndrome
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
424
|
28
|
0.100 |
None |
1.000 |
13 |
|
1996 |
2018 |
Fetal Growth Retardation
|
phenotype |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications
|
Disease or Syndrome
|
1037
|
21
|
0.400 |
None |
1.000 |
13 |
|
2001 |
2019 |
Hyperaldosteronism
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
84
|
6
|
0.070 |
None |
1.000 |
7 |
|
1999 |
2019 |
Mineralocorticoid Excess Syndrome, Apparent
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
8
|
1
|
0.550 |
None |
1.000 |
7 |
1
|
1996 |
2019 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.070 |
None |
1.000 |
7 |
|
1998 |
2017 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.060 |
None |
1.000 |
6 |
|
2004 |
2020 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.060 |
None |
1.000 |
6 |
|
2004 |
2020 |
Hypernatremia
|
phenotype |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
59
|
3
|
0.050 |
None |
1.000 |
5 |
|
1999 |
2014 |
Cushing Syndrome
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
126
|
9
|
0.040 |
None |
1.000 |
4 |
|
2003 |
2019 |
Choriocarcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
431
|
2
|
0.040 |
None |
1.000 |
4 |
|
1996 |
2010 |
Anxiety
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1048
|
287
|
0.040 |
None |
1.000 |
4 |
|
2012 |
2019 |
Anxiety Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
840
|
163
|
0.040 |
None |
1.000 |
4 |
|
2012 |
2019 |
Adenoma
|
group |
Neoplasms
|
Neoplastic Process
|
1183
|
103
|
0.040 |
None |
1.000 |
4 |
|
2001 |
2013 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
2780
|
385
|
0.030 |
None |
1.000 |
3 |
|
2008 |
2018 |
Pregnancy associated hypertension
|
phenotype |
Female Urogenital Diseases and Pregnancy Complications; Cardiovascular Diseases
|
Disease or Syndrome
|
186
|
43
|
0.030 |
None |
1.000 |
3 |
|
2013 |
2018 |
Polycystic Ovary Syndrome
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Disease or Syndrome
|
988
|
363
|
0.030 |
None |
0.667 |
3 |
|
2010 |
2018 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.030 |
None |
1.000 |
3 |
|
2002 |
2019 |
early pregnancy
|
phenotype |
|
Disease or Syndrome
|
273
|
8
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2020 |
Endometriosis
|
disease |
Female Urogenital Diseases and Pregnancy Complications
|
Disease or Syndrome
|
1188
|
274
|
0.020 |
None |
1.000 |
2 |
|
2007 |
2010 |
Metabolic Diseases
|
group |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
945
|
50
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2018 |
Colon Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
2832
|
275
|
0.020 |
None |
1.000 |
2 |
|
2001 |
2014 |
Carcinoma of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4081
|
1204
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2018 |
Adrenal Cushing's syndrome
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
120
|
9
|
0.020 |
None |
1.000 |
2 |
|
2003 |
2004 |